Business Standard

Govt revises NLEM: Slashes prices of 39 commonly used medicines

Revising the 'National List of Essential Medicines', the central govenrment has slashed the prices of 39 commonly used drugs.

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing

IANS New Delhi

Revising the 'National List of Essential Medicines' (NLEM), the central govenrment has slashed the prices of 39 commonly used drugs.

The prices were slashed for the anti-cancer, anti-diabetes, antiviral, antibacterial, antiretroviral, anti-TB drugs, and also for some that are used in Covid treatment.

The experts working on the NLEM list have deleted 16 odd drugs from the list.

The Indian Council of Medical Research (ICMR) has been working for a long time to extend price control on medicines.

The commonly used drugs, which were brought under the price cap includes Teneligliptin -- an anti diabetes drug, popular anti-TB drugs, Ivermectin -- used in Covid treatment, Rotavirus vaccine, among others.

 

The government had begun an exercise for the revision of the NLEM, which was notified in 2015 and implemented in 2016.

It is a departure from the present practice, where all essential medicines automatically go under price control.

The Standing National Committee on Medicines was tasked with preparing the list of which medicines should be available in adequate numbers and assured quantity.

The committee headed by Balram Bhargava, Secretary in the Department of Health Research and Director General of the ICMR, send the list to a second committee comprising senior officials from NITI Aayog, Health Secretary and Secretary in the Department of Pharmaceuticals, which decides on which drugs are to be put under the price cap.

--IANS

avr/shs/in

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 04 2021 | 1:06 PM IST

Explore News